The prevalence of chronic kidney disease (CKD) and diabetes mellitus (DM) is increasing worldwide. DM is one of the most common causes of CKD.
Patients with DM and CKD have specific characteristics and the treatment of these patients requires an individual approach, including the pharmacotherapy of diabetes. Number of antidiabetic agents requires treatment discontinuation or dose reduction.
Early diagnosis and adequate treatment from the time of diagnosis is important for the prevention and reducing the progression of CKD.